4Ghani F, Wu AH, Graff L, et al. Role of heart type fatty acid-binding protein in early detection of acute myocardial inraction[J]. Clin Chem, 2000,46(5) :718-719. 被引量：1
3Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol, 2003, 41(4 Suppl S): 37S-42S. 被引量：1
5Malasky BR, Alpert JS. Diagnosis of myocardial injury by biochemical markers: problems and promises. Cardiol Rev, 2002, 10(5): 306-317. 被引量：1
6e-Lemos JA, Morrow DA, Gibson CM, et al. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. J Am Coll Cardiol, 2002, 40(2): 238-244. 被引量：1
7Ghani F, Wu AH, Graff L, et al. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem, 2000, 46(5): 718-719. 被引量：1
8Rabitzsch G, Mair J, Lechleitner P, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem, 1995, 41(7): 966-978. 被引量：1
9Patti G, D'Ambrosio A, Mega S, et al. Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction. J Am Coll Cardiol, 2004, 43(1): 35-38. 被引量：1
10Langford EJ, Wainwright RJ, Martin JF. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol, 1996, 16(1): 51-55. 被引量：1
4Moro C,Berlan M.Cardiovascular and metabolic effects of natriuretic peptides[J].Fundam Clin Pharmacol,2006,20(1) :41-49. 被引量：1
5Ewald B,Ewald D,Thakkinstian A,et al.Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction[J].Intern. Med J,2008,38(2): 101-113. 被引量：1
6Moro C, Berlan M. Cardiovascular and metabolic effects of natriuretic peptides [J]. Fundam Clin Pharmacol, 2006, 20 (1): 41-49. 被引量：1
7Ewald B, Ewald D, Thakkinstian A, et al. Meta - analysis of B type natriuretic peptide and N- terminal pro B natriuretic peptide in the di- agnosis of clinical heart failure and population screening for left ventric- ular systolic dysfunction [J]. Intern Med J, 2008, 38 (2) : 101 - 113. 被引量：1
8Moro C, Berlan M. Cardiovascular and metabolic effects of natriuretic peptides [ J ]. Fundam Clin Pharmaco1,2006,20 (1) :41-49. 被引量：1
9Ewald B, Ewald D, Thakkinstian A, et al. Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and popu- lation screening for left ventricular systolic dysfunction [J]. Int Med J,2008,38(2) :101-113. 被引量：1
10Moro C, Berlan M.Cardiovascular and metabolic effects of natriuretle peptides[J].Fundam Clin Pharmacol, 2006, 20 ( 1 ) : 41-49. 被引量：1
